Ganesh Shinde added new article
Scleroderma Treatment Market Segment Overview, Analysis and Forecast by 2032
The global Scleroderma Treatment Market was valued at US$ 1.46 billion in 2021 and is predicted to grow at a 4.8% year-on-year rate to US$ 1.53 billion in FY 2022. Sales are predicted to grow at a CAGR of 5.45% between 2022 and 2032, reaching US$ 2.6 billion. Scleroderma is an autoimmune illness that affects the blood vessels, skin, muscles, and other organs. When exposed to cold, scleroderma...
0 Comments 0 Shares